**Core Concept**
Persistent trophoblastic disease encompasses a spectrum of gestational trophoblastic neoplasms that arise from the placental tissue. These conditions can follow a molar or non-molar pregnancy. Choriocarcinoma is a highly malignant form of gestational trophoblastic neoplasia characterized by the abnormal proliferation of cytotrophoblasts and syncytiotrophoblasts.
**Why the Correct Answer is Right**
Choriocarcinoma is the most common form of persistent trophoblastic disease that follows a non-molar pregnancy. This is because choriocarcinoma arises from the abnormal proliferation of cytotrophoblasts and syncytiotrophoblasts, which is a feature common to both molar and non-molar pregnancies. In contrast, invasive mole and placental site trophoblastic tumor are more commonly associated with molar pregnancies. Partial mole is a type of molar pregnancy itself, characterized by an abnormal karyotype of 45,X with a triploid complement of 69,XXY.
**Option A:** Choriocarcinoma is incorrect because it does not follow a non-molar pregnancy (choice A is actually the correct answer).
**Option B:** Invasive mole is incorrect because it is more commonly associated with molar pregnancies rather than non-molar pregnancies.
**Option C:** Placental site trophoblastic tumor is incorrect because it is a rare form of gestational trophoblastic neoplasia that arises from the placental bed, but it is not the most common form that follows a non-molar pregnancy.
**Option D:** Partial mole is incorrect because it is a type of molar pregnancy itself, not a form of persistent trophoblastic disease that follows a non-molar pregnancy.
**Clinical Pearl / High-Yield Fact**
Choriocarcinoma often presents with vaginal bleeding, uterine enlargement, and elevated levels of beta-hCG. Early diagnosis and treatment are crucial to prevent metastasis and improve outcomes.
**β Correct Answer: A. Choriocarcinoma**
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.